135 related articles for article (PubMed ID: 31872854)
1. Genetic interactions between INPP4B and RAD50 is prognostic of breast cancer survival.
Chen X; Theobard R; Zhang J; Dai X
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31872854
[TBL] [Abstract][Full Text] [Related]
2. INPP4B and RAD50 have an interactive effect on survival after breast cancer.
Dai X; Fagerholm R; Khan S; Blomqvist C; Nevanlinna H
Breast Cancer Res Treat; 2015 Jan; 149(2):363-71. PubMed ID: 25528023
[TBL] [Abstract][Full Text] [Related]
3. Loss of tumor suppressor inositol polyphosphate 4-phosphatase type B impairs DNA double-strand break repair by destabilization of DNA tethering protein Rad50.
Sun Y; Ning X; Fan J; Hu J; Jiang Y; Hu Z; Paulo JA; Liu J; Qiu X; Xu H; Fu S; Gygi SP; Zhang J; Zhou C
Cell Death Dis; 2020 Apr; 11(4):292. PubMed ID: 32341333
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients.
Karamat U; Ejaz S
Curr Cancer Drug Targets; 2021; 21(2):163-176. PubMed ID: 33038913
[TBL] [Abstract][Full Text] [Related]
5. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
Allen-Brady K; Camp NJ
BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
[TBL] [Abstract][Full Text] [Related]
7. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
Asleh-Aburaya K; Sheffield BS; Kos Z; Won JR; Wang XQ; Gao D; Wolber R; Gilks CB; Bernard PS; Chia SK; Nielsen TO
Histopathology; 2017 Jan; 70(2):185-194. PubMed ID: 27402148
[TBL] [Abstract][Full Text] [Related]
8. Genetic interactions between ANLN and KDR are prognostic for breast cancer survival.
Dai X; Chen X; Hakizimana O; Mei Y
Oncol Rep; 2019 Dec; 42(6):2255-2266. PubMed ID: 31578580
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer.
Xu WH; Wang J; Sheng HY; Qu YY; Wang HK; Zhu Y; Shi GH; Zhang HL; Ye DW
J Cell Biochem; 2020 Jun; 121(5-6):3124-3134. PubMed ID: 31886567
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
[TBL] [Abstract][Full Text] [Related]
13. Functional identification of a novel transcript variant of INPP4B in human colon and breast cancer cells.
Croft A; Guo ST; Sherwin S; Farrelly M; Yan XG; Zhang XD; Jiang CC
Biochem Biophys Res Commun; 2017 Mar; 485(1):47-53. PubMed ID: 28189677
[TBL] [Abstract][Full Text] [Related]
14. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.
Hamdi Y; Soucy P; Adoue V; Michailidou K; Canisius S; Lemaçon A; Droit A; Andrulis IL; Anton-Culver H; Arndt V; Baynes C; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Borresen-Dale AL; Brand JS; Brauch H; Brenner H; Broeks A; Burwinkel B; Chang-Claude J; ; Couch FJ; Cox A; Cross SS; Czene K; Darabi H; Dennis J; Devilee P; Dörk T; Dos-Santos-Silva I; Eriksson M; Fasching PA; Figueroa J; Flyger H; García-Closas M; Giles GG; Goldberg MS; González-Neira A; Grenaker-Alnæs G; Guénel P; Haeberle L; Haiman CA; Hamann U; Hallberg E; Hooning MJ; Hopper JL; Jakubowska A; Jones M; Kabisch M; Kataja V; Lambrechts D; Le Marchand L; Lindblom A; Lubinski J; Mannermaa A; Maranian M; Margolin S; Marme F; Milne RL; Neuhausen SL; Nevanlinna H; Neven P; Olswold C; Peto J; Plaseska-Karanfilska D; Pylkäs K; Radice P; Rudolph A; Sawyer EJ; Schmidt MK; Shu XO; Southey MC; Swerdlow A; Tollenaar RA; Tomlinson I; Torres D; Truong T; Vachon C; Van Den Ouweland AM; Wang Q; Winqvist R; ; Zheng W; Benitez J; Chenevix-Trench G; Dunning AM; Pharoah PD; Kristensen V; Hall P; Easton DF; Pastinen T; Nord S; Simard J
Oncotarget; 2016 Dec; 7(49):80140-80163. PubMed ID: 27792995
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome.
Dai X; Li L; Liu X; Hu W; Yang Y; Bai Z
G3 (Bethesda); 2014 Nov; 5(1):81-91. PubMed ID: 25425654
[TBL] [Abstract][Full Text] [Related]
16. RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer.
He M; Di GH; Cao AY; Hu Z; Jin W; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 May; 133(1):111-6. PubMed ID: 21811815
[TBL] [Abstract][Full Text] [Related]
17. INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.
Jin H; Yang L; Wang L; Yang Z; Zhan Q; Tao Y; Zou Q; Tang Y; Xian J; Zhang S; Jing Y; Zhang L
J Exp Clin Cancer Res; 2018 Jan; 37(1):8. PubMed ID: 29343273
[TBL] [Abstract][Full Text] [Related]
18. RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Fan C; Zhang J; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2018 Oct; 143(8):1935-1942. PubMed ID: 29726012
[TBL] [Abstract][Full Text] [Related]
19. SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.
Dzneladze I; Woolley JF; Rossell C; Han Y; Rashid A; Jain M; Reimand J; Minden MD; Salmena L
PLoS One; 2018; 13(2):e0191510. PubMed ID: 29415082
[TBL] [Abstract][Full Text] [Related]
20. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
